Kosuke Shiki

3PUBLICATIONS
4CO-AUTHORS
Exercise physiologyEpidemiological methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 25, 2023
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY).

Daisuke Yabe, Kosuke Shiki, Gosuke Homma

|Apr 08, 2021
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.

Daisuke Yabe, Kosuke Shiki, Keiko Suzaki

|Nov 07, 2019
Efficacy and safety of empagliflozin as add-on to insulin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Hirohito Sone, Tatsuroh Kaneko, Kosuke Shiki

Pageof 1

Frequent Collaborators

2 joint publications

Daisuke Yabe

1 joint publications

Hirohito Sone

1 joint publications

Gosuke Homma

1 joint publications

Yuji Ogura